Chlorophenothane


Curated chemical-phenotype interactions from CTD
GO IDGO nameInteraction typeReference
GO:0000723 Telomere maintenance Affects phenotype PMID:23774483
GO:0001503 Ossification Increases phenotype PMID:25014179
GO:0002024 Diet induced thermogenesis Affects phenotype PMID:25076055
GO:0004784 Superoxide dismutase activity Decreases phenotype PMID:24820114; PMID:24968063
GO:0005243 Gap junction channel activity Decreases phenotype PMID:26023933
GO:0006007 Glucose catabolic process Decreases phenotype PMID:29477483
GO:0006021 Inositol biosynthetic process Increases phenotype PMID:29477483
GO:0006094 Gluconeogenesis Decreases phenotype PMID:29477483
GO:0006096 Glycolytic process Affects phenotype PMID:31724279
GO:0006114 Glycerol biosynthetic process Decreases phenotype PMID:29477483
GO:0006304 Dna modification Decreases phenotype PMID:28659405
GO:0006306 Dna methylation Decreases phenotype PMID:20064773; PMID:28263910; PMID:30207508; PMID:31079544
GO:0006526 Arginine biosynthetic process Decreases phenotype PMID:29477483
GO:0006529 Asparagine biosynthetic process Decreases phenotype PMID:29477483
GO:0006532 Aspartate biosynthetic process Increases phenotype PMID:29477483
GO:0006545 Glycine biosynthetic process Affects phenotype PMID:29477483
GO:0006561 Proline biosynthetic process Decreases phenotype PMID:29477483
GO:0006592 Ornithine biosynthetic process Decreases phenotype PMID:29477483
GO:0006750 Glutathione biosynthetic process Decreases phenotype PMID:24820114; PMID:24968063
GO:0006915 Apoptotic process Increases phenotype PMID:15820723
GO:0006979 Response to oxidative stress Increases phenotype PMID:15820723
GO:0007160 Cell-matrix adhesion Increases phenotype PMID:24820114
GO:0007613 Memory Decreases phenotype PMID:16968864
GO:0008219 Cell death Increases phenotype PMID:29477483
GO:0008283 Cell population proliferation Affects phenotype PMID:20623010; PMID:24968063; PMID:25014179
GO:0008285 Negative regulation of cell population proliferation Increases phenotype PMID:29149346; PMID:32949729
GO:0009085 Lysine biosynthetic process Decreases phenotype PMID:29477483
GO:0009086 Methionine biosynthetic process Decreases phenotype PMID:29477483
GO:0009097 Isoleucine biosynthetic process Decreases phenotype PMID:29477483
GO:0009098 Leucine biosynthetic process Decreases phenotype PMID:29477483
GO:0009099 Valine biosynthetic process Decreases phenotype PMID:29477483
GO:0010424 Dna methylation on cytosine within a cg sequence Affects phenotype PMID:38294233
GO:0019344 Cysteine biosynthetic process Affects phenotype PMID:29477483
GO:0019393 Glucarate biosynthetic process Increases phenotype PMID:29477483
GO:0022602 Ovulation cycle process Affects phenotype PMID:16299097
GO:0031324 Negative regulation of cellular metabolic process Increases phenotype PMID:35413382
GO:0031959 Mineralocorticoid receptor signaling pathway Increases phenotype PMID:29149346
GO:0032715 Negative regulation of interleukin-6 production Increases phenotype PMID:31542660
GO:0032755 Positive regulation of interleukin-6 production Increases phenotype PMID:31542660
GO:0032776 Dna methylation on cytosine Affects phenotype PMID:31682807
GO:0032868 Response to insulin Affects phenotype PMID:25076055
GO:0033148 Positive regulation of intracellular estrogen receptor signaling pathway Increases phenotype PMID:26022396; PMID:26139245
GO:0033610 Oxalate biosynthetic process Decreases phenotype PMID:29477483
GO:0033993 Response to lipid Decreases phenotype PMID:28659405
GO:0034587 Pirna processing Increases phenotype PMID:30207508
GO:0035938 Estradiol secretion Increases phenotype PMID:30817981
GO:0040015 Negative regulation of multicellular organism growth Increases phenotype PMID:31682807
GO:0040029 Epigenetic regulation of gene expression Affects phenotype PMID:30207508
GO:0042427 Serotonin biosynthetic process Decreases phenotype PMID:28263910
GO:0042554 Superoxide anion generation Affects phenotype PMID:31923579
GO:0042593 Glucose homeostasis Decreases phenotype PMID:25076055
GO:0042696 Menarche Affects phenotype PMID:16299097
GO:0043433 Negative regulation of dna-binding transcription factor activity Increases phenotype PMID:26022396
GO:0043651 Linoleic acid metabolic process Affects phenotype PMID:29477483
GO:0045444 Fat cell differentiation Increases phenotype PMID:25014179
GO:0046034 Atp metabolic process Affects phenotype PMID:32949729
GO:0046323 Glucose import Affects phenotype PMID:31923579
GO:0046370 Fructose biosynthetic process Affects phenotype PMID:29477483
GO:0050679 Positive regulation of epithelial cell proliferation Decreases phenotype PMID:28659405
GO:0050847 Progesterone receptor signaling pathway Decreases phenotype PMID:26022396
GO:0050890 Cognition Decreases phenotype PMID:16818570; PMID:16968864; PMID:26414943; PMID:29648420
GO:0051091 Positive regulation of dna-binding transcription factor activity Increases phenotype PMID:26022396
GO:0051882 Mitochondrial depolarization Increases phenotype PMID:31404653
GO:0060612 Adipose tissue development Increases phenotype PMID:25076055; PMID:31746186
GO:0061744 Motor behavior Affects phenotype PMID:29648420
GO:0071514 Genomic imprinting Affects phenotype PMID:30005188
GO:0072593 Reactive oxygen species metabolic process Increases phenotype PMID:24820114; PMID:24968063; PMID:31724279; PMID:31923579
GO:0080182 Histone h3-k4 trimethylation Affects phenotype PMID:38294233
GO:0098609 Cell-cell adhesion Decreases phenotype PMID:24820114
GO:0098781 Ncrna transcription Increases phenotype PMID:30207508
GO:1900222 Negative regulation of amyloid-beta clearance Increases phenotype PMID:34045954
GO:1900223 Positive regulation of amyloid-beta clearance Affects phenotype PMID:34045954
GO:1900535 Palmitic acid biosynthetic process Increases phenotype PMID:29477483
GO:1901142 Insulin metabolic process Affects phenotype PMID:31746186
GO:1901538 Changes to dna methylation involved in embryo development Affects phenotype PMID:30005188
GO:1990349 Gap junction-mediated intercellular transport Decreases phenotype PMID:35413382
GO:2000610 Negative regulation of thyroid hormone generation Increases phenotype PMID:31284115
GO:2001057 Reactive nitrogen species metabolic process Affects phenotype PMID:31923579

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.